Xia Jiang

610 total citations
36 papers, 461 citations indexed

About

Xia Jiang is a scholar working on Pharmacology, Molecular Biology and Surgery. According to data from OpenAlex, Xia Jiang has authored 36 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Xia Jiang's work include Healthcare and Venom Research (5 papers), Acupuncture Treatment Research Studies (5 papers) and Pain Mechanisms and Treatments (4 papers). Xia Jiang is often cited by papers focused on Healthcare and Venom Research (5 papers), Acupuncture Treatment Research Studies (5 papers) and Pain Mechanisms and Treatments (4 papers). Xia Jiang collaborates with scholars based in China, Hong Kong and Japan. Xia Jiang's co-authors include Wenjian Tang, Wenjuan Wang, Zhiwei Chen, Hua‐Li Qin, Zhiwei Chen, Yingying Xu, Fen Ji, Ziwen Zhang, Wenzhan Tu and Songhe Jiang and has published in prestigious journals such as Chemosphere, Frontiers in Immunology and European Journal of Medicinal Chemistry.

In The Last Decade

Xia Jiang

33 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Jiang China 12 130 114 82 79 58 36 461
Umesh Kumar Singh India 7 289 2.2× 48 0.4× 70 0.9× 45 0.6× 27 0.5× 12 656
Thorsten J. Maier Germany 14 247 1.9× 190 1.7× 64 0.8× 57 0.7× 14 0.2× 24 670
Marc Lecomte France 12 212 1.6× 164 1.4× 101 1.2× 102 1.3× 7 0.1× 21 758
Mona K. Tawfik Egypt 16 195 1.5× 52 0.5× 27 0.3× 84 1.1× 24 0.4× 39 586
Noriaki Matsumoto Japan 12 175 1.3× 48 0.4× 146 1.8× 75 0.9× 54 0.9× 26 512
Adam Lauver United States 11 144 1.1× 137 1.2× 97 1.2× 32 0.4× 6 0.1× 25 584
Yucai Chen China 13 172 1.3× 60 0.5× 15 0.2× 32 0.4× 71 1.2× 24 434
Net Daş-Evcimen Türkiye 9 245 1.9× 65 0.6× 95 1.2× 124 1.6× 23 0.4× 15 623

Countries citing papers authored by Xia Jiang

Since Specialization
Citations

This map shows the geographic impact of Xia Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Jiang more than expected).

Fields of papers citing papers by Xia Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Jiang. The network helps show where Xia Jiang may publish in the future.

Co-authorship network of co-authors of Xia Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Jiang. A scholar is included among the top collaborators of Xia Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Jiang. Xia Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Dongmei, Yimin Zhu, Bin Wang, et al.. (2025). Solubility Determination, Hansen Solubility Parameter, Molecular Simulation, and Thermodynamic Properties of 1,3-Diaminoguanidine Monohydrochloride in 12 Monosolvents from 273.15 to 323.15 K. Journal of Chemical & Engineering Data. 70(4). 1769–1781. 1 indexed citations
2.
Ding, Fenghua, et al.. (2025). RRM2 attenuates the renal tubular ferroptosis in diabetic kidney disease through PI3K/Akt/Nrf2 pathway. World Journal of Diabetes. 16(11). 111223–111223.
3.
Jiang, Shouxiang, Guojun Zheng, Xiangyu Sun, et al.. (2024). Solubility Determination and Data Correlation of Paliperidone in Different Pure Solvents at 288.15 to 328.15 K. Journal of Chemical & Engineering Data. 70(1). 627–638. 1 indexed citations
4.
Feng, Huan & Xia Jiang. (2024). Serum Podoplanin Levels as a Potential Biomarker for Diabetic Nephropathy Progression: A Cross-Sectional Study. Diabetes Metabolic Syndrome and Obesity. Volume 17. 4701–4710. 2 indexed citations
5.
Wang, Min, Tian Tian, Siyuan Jiang, et al.. (2024). Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson’s disease through Mfn2-cGAS signaling. Journal of Neuroinflammation. 21(1). 81–81. 33 indexed citations
6.
Liu, Ning, et al.. (2024). TUFM in health and disease: exploring its multifaceted roles. Frontiers in Immunology. 15. 1424385–1424385. 2 indexed citations
7.
Ye, Fang, Zhiyi Zhang, Xinyu Li, et al.. (2023). Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2. Cell Discovery. 9(1). 118–118. 8 indexed citations
8.
Zhao, Bin & Xia Jiang. (2023). Biostatistical Analysis on Synergetic Therapy of the Three Plants. Journal of Biomedical Research & Environmental Sciences. 4(4). 747–759. 1 indexed citations
9.
Jiang, Xia, et al.. (2022). Electroacupuncture Suppresses CCI-Induced Neuropathic Pain through GABAA Receptors. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 9 indexed citations
10.
Zuo, Jiawei, et al.. (2021). Design and synthesis of novel glycyrrhetin ureas as anti-inflammatory agents for the treatment of acute kidney injury. Bioorganic Chemistry. 110. 104755–104755. 11 indexed citations
11.
Zhao, Li, et al.. (2021). Six-month versus nine-month therapy for intestinal tuberculosis: a protocol for a randomized controlled study. Annals of Palliative Medicine. 10(8). 9233–9238. 1 indexed citations
12.
Jiang, Xia, Ziwen Zhang, Jiawei Zuo, et al.. (2021). Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease. European Journal of Medicinal Chemistry. 223. 113735–113735. 42 indexed citations
13.
Zhang, Ziwen, et al.. (2020). The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors. European Journal of Medicinal Chemistry. 201. 112273–112273. 23 indexed citations
14.
Zuo, Jiawei, Shi‐Meng Wang, Xia Jiang, et al.. (2020). Design, synthesis and biological evaluation of novel arylpropionic esters for the treatment of acute kidney injury. Bioorganic Chemistry. 105. 104455–104455. 6 indexed citations
15.
Li, Siwen, et al.. (2019). Sodium/calcium overload and Sirt1/Nrf2/OH-1 pathway are critical events in mercuric chloride-induced nephrotoxicity. Chemosphere. 234. 579–588. 33 indexed citations
16.
Xu, Yingying, Ziwen Zhang, Xia Jiang, et al.. (2019). Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies. European Journal of Medicinal Chemistry. 181. 111598–111598. 41 indexed citations
17.
Chen, Zhiwei, Huiping Wang, Wenjuan Wang, et al.. (2017). Pterostilbene protects against uraemia serum-induced endothelial cell damage via activation of Keap1/Nrf2/HO-1 signaling. International Urology and Nephrology. 50(3). 559–570. 20 indexed citations
18.
Jiang, Xia, et al.. (2016). Comparison of high-flux hemodialysis with hemodialysis filtration in treatment of uraemic pruritus: a randomized controlled trial. International Urology and Nephrology. 48(9). 1533–1541. 31 indexed citations
20.
Jiang, Xia, et al.. (1998). Metabolism of Transforming Growth Factor-β in Patients Receiving Hemodialysis Especially Those with Renal Osteodystrophy. Renal Failure. 20(1). 135–145. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026